Ryzodeg®

About Aytu BioScience

Aytu BioScience is a commercial-stage biopharmaceutical company with a mission to identify, acquire, and commercialize novel therapeutics for patients with high unmet medical needs. Its strategy centers on building a diversified portfolio of commercial products and late-stage development candidates, primarily in rare pediatric and central nervous system disorders. The company generates revenue from its commercial assets while advancing its pipeline to drive future growth. Aytu's focus on underserved markets aims to create significant value for patients and shareholders.

Therapeutic Areas